Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 328 entries
View as:

S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00041067 Org: User:
Start: 09/30/02 End: 01/31/12 Due: 01/31/13

S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix

Phase: N/A Priority: Normal
NCT ID: NCT00072540 Org: User:
Start: - End: - Due: -

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04511013 Org: User:
Start: 01/06/21 End: 06/30/27 Due: 06/30/28

S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00100789 Org: User:
Start: 01/31/05 End: 02/29/08 Due: 02/28/09

S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01059734 Org: User:
Start: 06/30/10 End: 06/30/12 Due: 06/30/13

SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002571 Org: User:
Start: 06/30/94 End: 07/31/11 Due: 07/31/12

S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04155034 Org: User:
Start: 05/04/20 End: 11/15/29 Due: 11/15/30

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02562716 Org: User:
Start: 01/06/16 End: 09/26/22 Due: 09/26/23

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Phase: N/A Priority: Normal
NCT ID: NCT05806515 Org: User:
Start: 03/01/24 End: 06/30/28 Due: 06/30/29

Study to Test AKR1C3-Activated Prodrug OBI-3424 (OBI-3424) in Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Phase: N/A Priority: Normal
NCT ID: NCT04315324 Org: User:
Start: 02/08/21 End: 08/01/32 Due: 08/01/33

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT04625647 Org: User:
Start: 04/16/21 End: 12/31/27 Due: 12/31/28

S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00070018 Org: User:
Start: 02/29/04 End: 01/08/15 Due: 01/08/16

S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat

Phase: N/A Priority: Normal
NCT ID: NCT00006994 Org: User:
Start: 11/30/01 End: 04/30/06 Due: 04/30/07

S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002772 Org: User:
Start: 07/31/96 End: 02/29/04 Due: 02/28/05

S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00919425 Org: User:
Start: 04/30/99 End: 01/31/12 Due: 01/31/13

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Phase: N/A Priority: Normal
NCT ID: NCT06807437 Org: User:
Start: 06/28/25 End: 11/01/27 Due: 11/01/28

S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02438722 Org: User:
Start: 05/07/15 End: 06/15/25 Due: 06/15/26

S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00006721 Org: User:
Start: 03/31/01 End: 12/31/25 Due: 12/31/26

Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT03845296 Org: User:
Start: 04/16/19 End: 09/21/24 Due: 09/21/25

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03723928 Org: User:
Start: 09/17/18 End: 12/01/36 Due: 12/01/37

S0902 Bendamustine and Rituximab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Not Responded to Previous Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00939328 Org: User:
Start: 09/30/09 End: 09/30/10 Due: 09/30/11

S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00337168 Org: User:
Start: 10/31/06 End: 01/31/13 Due: 01/31/14

S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT00030901 Org: User:
Start: 02/29/00 End: 11/30/11 Due: 11/30/12

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

Phase: N/A Priority: Normal
NCT ID: NCT04496739 Org: User:
Start: 10/23/20 End: 06/01/28 Due: 06/01/29

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT00002849 Org: User:
Start: 11/30/96 End: 07/31/00 Due: 07/31/01